Home | Welcome to Contract Pharma   
Last Updated Thursday, October 30 2014
Print

Breaking News

October 2, 2012
Gains rights to ASP015K for immune-mediated inflammatory diseases  Read More »
October 2, 2012
Receives extended license, expands infrastructure and staff  Read More »
October 1, 2012
Will supply extended-release Qsymia capsules  Read More »
October 1, 2012
Will work to develop three clinical candidates  Read More »
October 1, 2012
Aims to improve health outcomes  Read More »
October 1, 2012
Heller joins senior management team  Read More »
October 1, 2012
Relocates business unit to Florham Park, NJ  Read More »
September 28, 2012
Invests $32 million for research and clinical production  Read More »
September 28, 2012
Will combine expertise to create efficiencies  Read More »
September 28, 2012
To supply preclinical materials for drug optimization  Read More »
September 28, 2012
Will provide cryogenic storage and distribution of PLX cells  Read More »
September 28, 2012
Further instruction expected by October 31st  Read More »
September 27, 2012
Plans continued advancement of AF drug in North America  Read More »
September 27, 2012
Services aim to solve drug delivery challenges  Read More »
September 27, 2012
Launches strategic sourcing solutions unit  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On